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Abstract Kawasaki disease (KD) is a paediatric vasculitis
with coronary artery aneurysms (CAA) as its main compli-
cation. Two guidelines exist regarding the follow-up of
patients after KD, by the American Heart Association and
the Japanese Circulation Society. After the acute phase,
CAA-negative patients are checked for cardiovascular risk
assessment or with ECG and echocardiography until 5
years after the disease. In CAA-positive patients, monitor-
ing includes myocardial perfusion imaging, conventional
angiography and CT-angiography. However, the invasive
nature and high radiation exposure do not reflect technical
advances in cardiovascular imaging. Newer techniques,
such as cardiac MRI, are mentioned but not directly imple-
mented in the follow-up. Cardiac MRI can be performed to
identify CAA, but also evaluate functional abnormalities,
ischemia and previous myocardial infarction including
adenosine stress-testing. Low-dose CT angiography can be
implemented at a young age when MRI without anaesthesia
is not feasible. CT calcium scoring with a very low radia-
tion dose can be useful in risk stratification years after the
disease. By incorporating newer imaging techniques, detec-
tion of CAA will be improved while reducing radiation
burden and potential complications of invasive imaging
modalities. Based on the current knowledge, a possible
pathway to follow-up patients after KD is introduced.
Key Points
• Kawasaki disease is a paediatric vasculitis with coronary
aneurysms as major complication.
• Current guidelines include invasive, high-radiation modali-
ties not reflecting new technical advances.
• Cardiac MRI can provide information on coronary anatomy
as well as cardiac function.
• (Low-dose) CT-angiography and CT calcium score can also
provide important information.
• Current guidelines for follow-up of patients with KD need to
be revised.
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Introduction
Kawasaki disease (KD) is an acute paediatric vasculitis that
mainly affects children younger than 5 years of age. Although
the exact cause is still unknown, it is thought to be caused by
an infectious agent in genetically predisposed children. This
fits with the observed epidemiology of seasonal occurrence
throughout the northern hemisphere, the increased incidence
in children of Japanese descent, and the established
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association with specific genetic polymorphisms [1, 2]. In
about 25 % of untreated patients, coronary artery aneurysms
(CAA) will develop during the acute phase of KD. Since the
introduction of high-dose intravenous immunoglobulin as ef-
fective treatment, the percentage of CAA has dropped to 5–
7 % for patients treated within 10 days after fever onset [3].
For patients not treated within 10 days, the rate of developing
aneurysms may be higher [4].
During CAA formation it is thought that an influx of in-
flammatory cells leads to dissociation and disruption of the
medial and internal elastic lamina layer. Even when the lumen
of the artery returns to its normal size, the artery wall remains
damaged, although the extent of the damage varies among
patients. In one autopsy study, active remodelling of the artery
was seen many years after the acute disease in children with
aneurysms [5]. The KD-related vasculopathy during follow-
upwith characteristic myointimal proliferation and/or layering
of thrombus can result in progressive stenosis, whichmay lead
to ischemic cardiomyopathy.
Calcification of the damaged artery is progressive after the
acute phase of the disease and may develop in coronary arter-
ies with lesions that persist or, although rarely, in transiently
dilated arteries when the vessel lumen has normalized [6]. The
extensive calcification of the coronary artery wall is typical of
the pathology observed in the remodelled lesional wall
(Fig. 1).
CAA are diagnosed by echocardiography during the acute
or subacute phase of the disease. CAA are traditionally clas-
sified according to the definitions of the Japanese Ministry of
Health: a luminal diameter of >3 mm in children <5 years of
age, >4 mm in children ≥5 years of age, or a diameter 1.5
times the size of an adjacent segment or an irregular lumen
in children ≥5 years of age. A giant aneurysm is defined as an
aneurysmwith an internal diameter of ≥8mmor a diameter >4
times that of an adjacent segment in children ≥5 years old [7,
8]. However, over the past years it has become clear that z-
scores, adjusted for body-surface area, may be a better indica-
tor of any serious enlargement [9, 10]. Using this approach, a
z-score of ≥2.5 is considered an aneurysm; a z-score of ≥10 is
a giant aneurysm.
It is clear that a 6 mm aneurysm in a 6-month-old child
represents a more severely damaged artery than a 6 mm aneu-
rysm in a 6-year old child. As z-scores might differ from the
traditional definitions, especially in younger and smaller chil-
dren, this may alter their (long-term) therapy and monitoring.
It should be emphasized that all patients who develop CAA
carry a lifelong increased risk for coronary thrombosis and
stenotic coronary lesions that may result in myocardial ische-
mia, infarction, and sudden death [11].
There has been much debate about the appropriate way to
follow-up on our KD patients, both with and without CAA.
Several imaging techniques have been proposed and different
Fig. 1 Coronary artery lesion in Kawasaki disease during follow-up.
Extensive calcification (arrow) with ossification and bone marrow
elements (insert, 400×) in the thrombosed and re-canalized left anterior
descending artery from the explanted heart of a 29-year-old man who
suffered from Kawasaki disease at age 3 years. The aneurysms
remodelled, and the patient was discharged from follow-up at the age of
7 years when the coronary artery appeared normal by echocardiogram.
The patient presented with progressive congestive symptoms at age
29 years and required cardiac transplantation. Characteristic ‘lotus root’
appearance of the artery results from thrombosis with recanalization
(stars). Only one lumen remains patent (far left). Haematoxylin and
eosin stain, 40×
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guidelines have been published. The aim of this paper was to
analyse the existing guidelines regarding the cardiovascular
follow-up of patients after KD and to propose a new pathway
for follow-up, based on the current knowledge and our own
experience.
Current guidelines
Among the many issues concerning clinical management of
patients with a history of KD, several controversies exist. One
of these is the timing and need for long-term follow-up. Two
consensus guidelines have been published, one by the Amer-
ican Heart Association (AHA) in 2004, and one by the Japa-
nese Circulation Society (JCS) in 2014 [8, 12]. These guide-
lines are summarized in Tables 1 and 2, starting at 1 year after
the acute disease. In both guidelines, patients are risk-stratified
based on the severity of the coronary artery lesions and like-
lihood of complications, including myocardial ischemia and
congestive heart failure.
In children without CAA or with early, transient coronary
artery dilatations, the AHA advises echocardiograms at initial
diagnosis and 2 and 6–8 weeks later. A repeat echocardiogram
at 1 year is considered optional. Subsequently, only periodic
assessment and counselling about cardiovascular risk factors
are recommended. To evaluate patients without CAA, the JCS
advises an ECG and echocardiogram at 1, 2, 6 and 12 months,
and a final evaluation at 5 years with an exercise ECG.
For patients diagnosed with persisting CAA after the acute
phase, both guidelines advise a more intensive and prolonged
follow-up with additional imaging modalities.
In children with small to medium aneurysms, the AHA
advises an annual routine follow-up and biennial stress testing
with myocardial nuclear perfusion scans. In case of large and/
or multiple or complex aneurysms within one artery, the AHA
recommends an invasive coronary angiography (CAG) to be
performed routinely 6–12 months after the disease onset and
repeated if the non-invasive stress test or clinical signs suggest
myocardial ischemia.. It should be noted that these guidelines
were last revised in 2004 andmany aspects of clinical care and
imaging have changed during this interval.
The JCS has recently published a revised guideline in
which the committee recommends follow-up for patients with
small aneurysms at 30 days after the acute illness with an
echocardiogram and ECG every 3 months until the dilatation
has disappeared. Patients with medium-sized aneurysms
should be more intensely evaluated, i.e., every 1–3 months
with (exercise) ECG, echocardiography and chest X-ray until
dilatation is no longer observed and should undergoMDCTor
MR Coronary Angiography (MRCA) every 5 years. This
scheme differs from the AHA guidelines.
For those with larger CAA, JCS advises a follow-up in a
risk-stratified manner using methods that are largely overlap-
ping the AHA recommendations. There are no specific rec-
ommendations for imaging modalities.
Concerns
There are two main drawbacks to the current guidelines for
follow-up imaging of patients with KD.
1) The invasive nature and high radiation exposure of the
advised follow-up modalities do not reflect technical ad-
vances in the field of cardiovascular imaging and result in
possible complications and unnecessary hazardous radia-
tion exposure.
2) Coronary aneurysms, especially those more distal in the
coronary tree, can be missed by echocardiography, poten-
tially leading to underestimation of disease severity.
Table 1 Summary of AHA guidelines regarding the follow-up of patients with Kawasaki disease, starting at 1 year
Risk level Diagnostic testing Interval Invasive testing
No CAA Cardiovascular risk assessment 5 years None
Transient CAAa Cardiovascular risk assessment 3–5 years None
Small-medium CAA (>3 mm





Invasive CAG if non-invasive
test suggests ischemia
Stress test with MPI 2 years
Large CAA (≥6 mm) or Multiple
or complex CAA in 1 artery
Echocardiogram + ECG one halfyear Invasive CAG after 6–12 months
and if any test or clinical finding
suggests ischemia
Stress test with MPI 1 year
Coronary artery obstruction Echocardiogram + ECG one halfyear Invasive CAG for therapeutic options
and if new onset or worsening
myocardial ischemia is suggested
Stress test with MPI 1 year
From: Newburger et al., Circulation. 2004;110(17):2747–718
CAG conventional angiography, MPI myocardial perfusion imaging
a Disappearing within 6–8 weeks after the onset of Kawasaki disease
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For this reason the use of alternative imaging methods
should be considered, and we suggest a feasible, accurate,
and sustainable follow-up scheme for KD as outlined below.
Cardiac Magnetic Resonance Imaging (CMRI)
CMRI is a robust imaging technique that is being widely
adopted by many centres for the evaluation of coronary artery
disease. Besides coronary anatomy, CMRI provides clinically
relevant information about myocardial ischemia, infarction, in-
flammation, and function. In experienced centres, cardiac nu-
clear scintigraphy has been largely abandoned because of low
sensitivity and high radiation exposure while being
outperformed by CMRI [13]. The current availability of CMRI
and expertise to apply CMRI varies greatly across centres.
Using a comprehensive CMRI protocol with adenosine
stress testing during the follow-up of 63 children with KD,
we showed that CMRI was safe and able to identify coronary
artery pathology, signs of ischemia, and previous myocardial
infarction [14]. CMRI, including MRCA, compared
favourably with echocardiography for the identification of
CAA; in six patients CAAwere missed by echocardiography
and identified by CMRI. Mavrogeni et al. compared coronary
MRCA to conventional CAG in 12 patients [15]. The two
techniques agreed completely in the detection of aneurysms,
and the maximal aneurysm diameters were similar. A larger
study from Suzuki et al. compared coronary MRCA in 106
patients with echocardiography and found 28 additional aneu-
rysms with MRCA [16]. When comparing coronary MRCA
to conventional CAG in 12 patients with imaging methods
<6 months apart, they found no significant difference in arte-
rial diameter using bright blood imaging, although one occlu-
sion of the circumflex artery was only detected by convention-
al CAG.
Table 2 Summary of JCS guidelines regarding the follow-up of patients with Kawasaki disease, starting at 1 year
Diagnostic testing Interval Invasive testing
No or transient CAAa Exercise ECG + echocardiogram Once, 5 years after disease b None
Small CAA (≤4 mm)a
- Regressed (Exercise) ECG + echocardiogram Annual until age 7
Triennial until age 16
None
- Persisting (Exercise) ECG + echocardiogram 3 months (until normalisation) None
- Regressed or persisting In patients ≥ 10 years after onset,
consider MDCT or MRCA
at final evaluation.
Medium CAA (>4 − <8 mm)a
A. CAA > 4 − <6 mm
- Regressed ECG + echocardiogram




Selective CAG on individual basis
- Persisting ECG + echocardiogram




Selective CAG on individual basis
B. CAA 6 − <8 mm
- Regressed ECG + echocardiogram
X-ray + exercise ECG when necessary/feasible
MDCT or MRCA
Appropriate combination of techniques c
Annual
5 years
Invasive CAG once during
convalescence and at time
of disappearance of dilatation
- Persisting ECG + echocardiogram
X-ray + exercise ECG when necessary/feasible
MDCT or MRCA
Appropriate combination of techniques c
3–6 months
5 years
Invasive CAG once during
convalescence and at time
of disappearance of dilatation
Giant CAA (≥8 mm)a Tailor-made treatment with appropriate
combination of (exercise) ECG,
echocardiogram and other techniques c
3–6 months Invasive CAG during early
convalescence phase
From: Group JCSJW: Circ J 2014, 78(10):2521–25628
MDCTMultidetector CT, MRCA MR Coronary Angiography
aMeasured at 30 days after the onset of KD
bAdditional follow-up from the second to fifth year and after the fifth year can be scheduled individually through consultation between patient and
physician
c Imaging techniques include stress echocardiography, stress myocardial perfusion scintigraphy, invasive coronary angiography (CAG), Intravenous
Ultrasound, Cardiac Magnetic Resonance Imaging, Magnetic Resonance Angiography and Multidetector CT
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Coronary artery evaluation can be easily combinedwith the
assessment of ischemia, infarction, ventricular dimensions,
and function within the same procedure, for which CMRI
has become the standard [17].
Based on our experience with CMRI in more than 150
patients with KD, a 2-step CMRI protocol was introduced in
2012. This CMRI is performed on a 1.5-T whole-body MRI
scanner equipped with cardiac software. The first step of this
CMRI protocol, consisting of MRCA and cardiac function
evaluation, is offered routinely during adolescence, when the
teenager is able to fully cooperate. An ECG-gated 3D steady-
state free precession sequence with T2 and fat saturation
prepulses is used to visualize the coronary arteries. If coronary
abnormalities have been observed by echocardiography on
two or more different occasions, the second-step of our CMRI
protocol is also performed in one procedure. If CAA are ob-
served unexpectedly upon the first step of CMRI, a second
step will subsequently be performed.
The second step involves the administration of intravenous
contrast (0.1 mmol/kg of gadolinium) and adenosine (140 ug/
kg/min) to detect myocardial perfusion abnormalities and
myocardial scar. Standard, commercially available, CMRI
techniques are used with fast single shot T1-weighted gradient
echo sequences (e.g., Turbo-FLASH, TFE) for perfusion im-
aging and segmented inversion recovery sequences for myo-
cardial scar imaging [18, 19].
We introduced this 2-step protocol because perfusion ab-
normalities and ischemia upon adenosine stress were detected
only in patients with persistent CAA.
Based on current data, it is unlikely that patients without
CAA will omit develop clinically significant cardiovascular
changes from their KD. However, in patients that are children
with missed CAA by echocardiography, long-term complica-
tions can still occur.
Low-radiation dose CT angiography
Although CMRI is a feasible technique in early adolescence,
assessment of younger children with CAA often requires gen-
eral anaesthesia and is, therefore, less suitable.
ECG-gated multislice CT is an attractive alternative imag-
ing technique for the younger patient. In teenagers with a
history of KD, CT-angiography confirmed all aneurysms, ste-
noses, and occlusions previously demonstrated by invasive
CAG [20]. In another study, aneurysms were detected by
CT-angiography in young children with a history of KD that
had been missed by echocardiography [21].
Although effective, traditional CT-angiography carries a
high radiation exposure, especially harmful for young chil-
dren. Low-radiation dose CT-angiography with prospective
ECG triggering is increasingly available. The use of next gen-
eration scanners decreases the radiation burden from a median
of 6.9 mSv per scan down to a median of 1 mSv on a 128 dual-
source CTscanner [22]. New imaging protocols can be used to
reduce the radiation dose for which the use of prospective
instead of retrospective ECG-triggering is most important.
The use of a single heart beat (high-pitch) protocol has been
shown to result in a reduction of the radiation dose require-
ments even further. On the other hand, studies are conflicting
as to whether the image quality is reduced in patients with a
relatively high heart rate, hence, in most children [22, 23].
With the use of iterative reconstruction, the image-to-noise
ratio can be reduced such that lower tube currents can be used
[24]. In children with congenital heart disease, this has already
shown to generate qualitatively excellent results, but studies
evaluating the coronary arteries in patients following acute
KD have not yet been performed [25].
A recent study in infants and young children with KD
showed that low-dose, free-breathing prospective ECG-
triggered CT-angiography without the use of beta-blockers
diagnosed all CAA detected with ultrasound plus the more
distal aneurysms and dilatations [26]. The data acquisition
window was set to 40 % of the RR-interval. The effective
radiation dose was calculated at 0.32 to 0.40 mSv, depending
on the patient’s age. Although this was a small study in 19
patients, it is very promising that good images could be ob-
tained without much radiation exposure and no pre-medica-
tion. Apart from replacing invasive CAG in an early stage of
follow-up, low-radiation dose CT-angiography can also be
used at a later stage to check for the development of stenosis
in patients with CAA.
CTcalcium scoring
Whereas CMRI is most useful for functional imaging, calcifi-
cations can be best picked up by CT imaging. CT calcium
scoring, a technique without intravenous contrast, measures
calcification in the coronary arteries, which was a strong
predictor of coronary events in a large adult cohort of
patients without evidence for cardiovascular disease at
enrolment [27]. It can be used to detect coronary calci-
fications that may have been missed by echocardiogra-
phy or CMRI and is associated with a very low radia-
tion dose of approximately 1 mSv or less with prospec-
tive ECG triggering [6, 28].
Although the exact clinical implication of small coronary
artery calcifications is still unknown, CTcalcium scoring may
be useful in risk-stratification of recently identified patients
whose aneurysms were missed in the past or not well moni-
tored since the acute phase. In such patients, the aneurysm
may have remodelled such that the lumen is of normal internal
diameter but the arterial wall is significantly damaged and
associated with calcium deposition. These patients are at risk
for late stenosis and must be carefully followed. Figure 2 il-
lustrates the different purposes of conventional techniques,
CMRI and CT.
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Recommendations
All current guidelines are based on the opinion of experts.
Evidence-based KD guidelines for cardiovascular assessment
of KD patients do not exist. Based on the current knowledge
and our own experience regarding different imaging
modalities, we herewith suggest a pathway for follow-up in
patients with KD into adulthood (Fig. 3). Advantages and
disadvantages of the different techniques are outlined in
Table 3.
By not performing frequent echocardiography after the
acute phase, costs are kept to a minimum. Furthermore, by
Fig. 2 Imaging techniques for the follow-up of Kawasaki disease. a
Echocardiogram of a giant aneurysm of the left main coronary artery
(LMCA) and LAD. b Stress and rest SPECT Technetium-99M scan
(myocardial perfusion scan) demonstrates ischemia of the inferior and
septal wall. c Conventional CAG shows a giant aneurysm of the LAD
and a smaller aneurysm of the right circumflex artery (RCX). d Cardiac
MRI shows an aneurysm of the LAD. e Cardiac MRI indicates a
myocardial infarction of the infero-posterior wall. f Multi-slice CT
contrast-enhanced angiography with calcified aneurysms of the
proximal LAD and right coronary artery (RCA). g CT calcium-score
with calcifications of the proximal LAD. h 3D-CT angiography with a
calcified aneurysm of the RCA
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detecting missed aneurysms or other lesions on CMRI, possi-
ble complications such as myocardial infarction can be
prevented. It must be stated that this pathway will depend on
the available technical quality and experience of a centre with
CMRI, which varies across centres.
For patients with CAA, the pathway must be customized
depending on the extent of the lesions. For instance, a young
child with giant aneurysms and suspected ischemia will require
invasive or CT-angiography, as well as MRI under general an-
aesthesia, repeated regularly as an individual approach, to ob-
tain the best interpretation of CAA and functional stenosis.
In contrast to infants and children, adolescents and adults
are able to report cardiac symptoms of ischemia. Asymptom-
atic adults with aneurysms must be followed for early signs of
ischemia upon (stress) echocardiography, but the frequency of
additional imaging studies can largely be guided by
Fig. 3 Flowchart for the monitoring of Kawasaki disease with current
imaging modalities starting at 1 year after the disease. aWhen information
is lacking about coronary arterial aneurysms (CAA) status, a calcium
score may be indicated as a screening method. If positive, a CMRI with
adenosine should be performed. bLong-term follow-up (cardiovascular
counselling) of risk group 1 may be dictated by national health care
policies and future studies. cAccording to the availability and
experience of a centre with (low-dose) CT angiography. dWhich of the
different revascularization options best improves prognosis is unclear to
date. eAdditional tests to evaluate for progression to stenotic lesions
Table 3 Advantages and
disadvantages of imaging
techniques
Imaging technique Advantage(s) Disadvantage(s)
Echocardiography Non-invasive
Cheap
Distal coronary arteries not visible
CAG Complete image of coronary tree Invasive, possible complications
Need of anaesthesia
Radiation exposure
CMRI Visualisation of distal aneurysms
Functional assessment
Need of anaesthesia in younger
children
CT-angiography Visualisation of distal aneurysms and stenosis
Widely available
Radiation exposure
CT-calciumscore Visualisation of calcifications late after disease
Low-radiation exposure
Not suitable for aneurysm information
Only applicable late after acute disease
CAG conventional angiography, CMRI Cardiac MRI
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symptoms. Since echocardiography in general is insensitive
for evaluating stenosis, symptomatic adults require other im-
aging techniques.
In addition to the techniquesmentioned above, in a selected
group of patients, conventional CAG can be considered when
a catheter-based intervention is contemplated. Invasive CAG
can be combined with fractional flow reserve to obtain hemo-
dynamic and structural data to help guide therapeutic deci-
sions [29]. These tests for interventional decision-making
have not often been reported in KD and are beyond the scope
of this article.
Future studies
Future studies are needed to evaluate the risks and benefits of
different cardiovascular imaging modalities and the most ap-
propriate timing of such imaging to optimize care for KD
patients. Evidence is lacking about the long-term effects of
KD, especially in children without prior evidence of CAA.
We might not appreciate late cardiovascular sequelae that
may become clinically important later in life. In order to an-
swer these questions, long-term follow-up is required.
Conclusion
In summary, we believe that the current guidelines for follow-
up of patients with KD need to be revised. By incorporating
new imaging techniques in our guidelines, detection of CAA
will be improved, while reducing the radiation burden and
potential complications of invasive angiography. This may
enable better adherence to the guidelines in clinical practice
and improve follow-up of patients into adulthood.
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